Skip to main content

Peer Review reports

From: Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials

Original Submission
8 Dec 2023 Submitted Original manuscript
14 Dec 2023 Reviewed Reviewer Report - Knut Hagen
19 Dec 2023 Reviewed Reviewer Report
15 Feb 2024 Author responded Author comments - Brett Dabruzzo
20 Feb 2024 Reviewed Reviewer Report - Knut Hagen
23 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 2
15 Feb 2024 Submitted Manuscript version 2
Publishing
23 Feb 2024 Editorially accepted
11 Mar 2024 Article published 10.1186/s10194-024-01736-z

You can find further information about peer review here.

Back to article page